- Home
- LFCR vs OM Comparison
LFCR vs OM Comparison
Compare LFCR & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- OM
- Stock Information
- Founded
- LFCR 1986
- OM 2003
- Country
- LFCR United States
- OM United States
- Employees
- LFCR N/A
- OM 354
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LFCR Health Care
- OM Health Care
- Exchange
- LFCR Nasdaq
- OM Nasdaq
- Market Cap
- LFCR 308.8M
- OM 247.1M
- IPO Year
- LFCR N/A
- OM 2020
- Fundamental
- Price
- LFCR $7.61
- OM $13.91
- Analyst Decision
- LFCR Buy
- OM Hold
- Analyst Count
- LFCR 4
- OM 1
- Target Price
- LFCR $8.00
- OM $22.00
- AVG Volume (30 Days)
- LFCR 108.3K
- OM 288.8K
- Earning Date
- LFCR 08-07-2025
- OM 08-06-2025
- Dividend Yield
- LFCR N/A
- OM N/A
- EPS Growth
- LFCR N/A
- OM N/A
- EPS
- LFCR N/A
- OM N/A
- Revenue
- LFCR $128,867,000.00
- OM $119,304,000.00
- Revenue This Year
- LFCR $4.78
- OM $12.37
- Revenue Next Year
- LFCR $12.02
- OM $10.52
- P/E Ratio
- LFCR N/A
- OM N/A
- Revenue Growth
- LFCR 0.47
- OM 2.47
- 52 Week Low
- LFCR $3.68
- OM $5.85
- 52 Week High
- LFCR $8.85
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- LFCR 53.94
- OM 43.41
- Support Level
- LFCR $7.33
- OM $13.60
- Resistance Level
- LFCR $7.73
- OM $14.35
- Average True Range (ATR)
- LFCR 0.30
- OM 0.60
- MACD
- LFCR 0.03
- OM 0.26
- Stochastic Oscillator
- LFCR 65.33
- OM 80.09
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.